Re-thinking pharma in the new normal
We are still reeling from the effects from the Covid-19 pandemic. The nature of socio-economic disruption has also impacted pharma operations across geographies. Conversely, it has also acted as a catalyst for the pharma industry to adapt and make dynamic …